nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—CBR1—Doxorubicin—breast cancer	0.437	1	CbGbCtD
Lubiprostone—CLCN2—epithelium—breast cancer	0.0112	0.102	CbGeAlD
Lubiprostone—CLCN2—uterus—breast cancer	0.00925	0.0846	CbGeAlD
Lubiprostone—CLCN2—pituitary gland—breast cancer	0.00908	0.083	CbGeAlD
Lubiprostone—CLCN2—female reproductive system—breast cancer	0.00831	0.076	CbGeAlD
Lubiprostone—CLCN2—adrenal gland—breast cancer	0.00811	0.0742	CbGeAlD
Lubiprostone—CBR1—mammary gland—breast cancer	0.00806	0.0737	CbGeAlD
Lubiprostone—CLCN2—endocrine gland—breast cancer	0.00704	0.0643	CbGeAlD
Lubiprostone—CBR1—nipple—breast cancer	0.00666	0.0609	CbGeAlD
Lubiprostone—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—breast cancer	0.0066	0.0534	CbGpPWpGaD
Lubiprostone—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—breast cancer	0.006	0.0485	CbGpPWpGaD
Lubiprostone—CLCN2—lymph node—breast cancer	0.00486	0.0445	CbGeAlD
Lubiprostone—CBR1—skin of body—breast cancer	0.00427	0.039	CbGeAlD
Lubiprostone—CBR1—endometrium—breast cancer	0.00402	0.0368	CbGeAlD
Lubiprostone—Alprostadil—PTGER1—breast cancer	0.00382	0.409	CrCbGaD
Lubiprostone—CBR1—uterus—breast cancer	0.00371	0.0339	CbGeAlD
Lubiprostone—CBR1—pituitary gland—breast cancer	0.00364	0.0333	CbGeAlD
Lubiprostone—CBR1—adipose tissue—breast cancer	0.00363	0.0332	CbGeAlD
Lubiprostone—CBR1—Arachidonic acid metabolism—ABCC1—breast cancer	0.00351	0.0284	CbGpPWpGaD
Lubiprostone—CLCN2—Ion channel transport—ATP7B—breast cancer	0.00344	0.0278	CbGpPWpGaD
Lubiprostone—CBR1—female reproductive system—breast cancer	0.00333	0.0305	CbGeAlD
Lubiprostone—CBR1—adrenal gland—breast cancer	0.00325	0.0297	CbGeAlD
Lubiprostone—CBR1—bone marrow—breast cancer	0.00315	0.0288	CbGeAlD
Lubiprostone—CBR1—Arachidonic acid metabolism—GPX2—breast cancer	0.00312	0.0253	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—GPX4—breast cancer	0.00309	0.025	CbGpPWpGaD
Lubiprostone—CBR1—female gonad—breast cancer	0.00303	0.0277	CbGeAlD
Lubiprostone—CBR1—Vincristine—Vinorelbine—breast cancer	0.00297	0.46	CbGdCrCtD
Lubiprostone—CBR1—endocrine gland—breast cancer	0.00282	0.0258	CbGeAlD
Lubiprostone—CBR1—NRF2 pathway—SLC2A10—breast cancer	0.00279	0.0225	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—ALDH3A1—breast cancer	0.00259	0.021	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—HPGDS—breast cancer	0.00238	0.0193	CbGpPWpGaD
Lubiprostone—CBR1—Vincristine—Vinblastine—breast cancer	0.00238	0.367	CbGdCrCtD
Lubiprostone—Dinoprostone—PTGER1—breast cancer	0.00235	0.252	CrCbGaD
Lubiprostone—CBR1—NRF2 pathway—SLC39A7—breast cancer	0.00231	0.0187	CbGpPWpGaD
Lubiprostone—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—breast cancer	0.0023	0.0186	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.00228	0.0184	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—PTGS1—breast cancer	0.00217	0.0175	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.00208	0.0169	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.00208	0.0169	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—SLC2A5—breast cancer	0.00203	0.0164	CbGpPWpGaD
Lubiprostone—CBR1—lymph node—breast cancer	0.00195	0.0178	CbGeAlD
Lubiprostone—CBR1—Arachidonic acid metabolism—CYP1B1—breast cancer	0.00184	0.0149	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—SLC39A6—breast cancer	0.00175	0.0142	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—COX11—breast cancer	0.00173	0.014	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.00173	0.014	CbGpPWpGaD
Lubiprostone—Dinoprostone—HPGDS—breast cancer	0.0016	0.171	CrCbGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.00158	0.0128	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.00152	0.0123	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.00152	0.0123	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GSTA3—breast cancer	0.00149	0.012	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—PLA2G4A—breast cancer	0.00147	0.0119	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—GPX1—breast cancer	0.00141	0.0114	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—CYP1A1—breast cancer	0.0014	0.0113	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GSTA4—breast cancer	0.00136	0.011	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GPX2—breast cancer	0.00133	0.0107	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GSTA2—breast cancer	0.00133	0.0107	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.00131	0.0106	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GSTA1—breast cancer	0.00128	0.0103	CbGpPWpGaD
Lubiprostone—CLCN2—Stimuli-sensing channels—RAF1—breast cancer	0.0012	0.0097	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ATP7B—breast cancer	0.0012	0.00968	CbGpPWpGaD
Lubiprostone—CBR1—Azacitidine—Gemcitabine—breast cancer	0.00112	0.173	CbGdCrCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ABCC1—breast cancer	0.00111	0.009	CbGpPWpGaD
Lubiprostone—Dinoprostone—SLCO1B1—breast cancer	0.00107	0.115	CrCbGaD
Lubiprostone—CBR1—NRF2 pathway—SLC2A2—breast cancer	0.00105	0.00851	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000946	0.00765	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—SYNJ2—breast cancer	0.000938	0.00759	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—TGFB2—breast cancer	0.000919	0.00743	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—SQSTM1—breast cancer	0.000869	0.00703	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—SLC5A5—breast cancer	0.000844	0.00683	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—PTGS2—breast cancer	0.00083	0.00671	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—NQO1—breast cancer	0.000815	0.00659	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—SLC2A1—breast cancer	0.000815	0.00659	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000787	0.00637	CbGpPWpGaD
Lubiprostone—CLCN2—Ion channel transport—RAF1—breast cancer	0.000782	0.00633	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000771	0.00624	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—HSP90AA1—breast cancer	0.000766	0.0062	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—EGR1—breast cancer	0.000757	0.00612	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—TFRC—breast cancer	0.000687	0.00556	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	0.000684	0.00554	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GSTP1—breast cancer	0.00068	0.0055	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—TGFBR2—breast cancer	0.00068	0.0055	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—HMOX1—breast cancer	0.00067	0.00542	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000662	0.00535	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000631	0.00511	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—HGF—breast cancer	0.000625	0.00505	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GSTM1—breast cancer	0.000625	0.00505	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	0.000622	0.00503	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	0.000622	0.00503	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—NRG1—breast cancer	0.000613	0.00496	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.00061	0.00493	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—HADHB—breast cancer	0.000589	0.00477	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000557	0.00451	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—PLG—breast cancer	0.000543	0.00439	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—FHL2—breast cancer	0.000539	0.00436	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000501	0.00406	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	0.000501	0.00405	CbGpPWpGaD
Lubiprostone—Dinoprostone—CYP19A1—breast cancer	0.000497	0.0532	CrCbGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	0.000485	0.00393	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000481	0.00389	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—GPX2—breast cancer	0.000447	0.00361	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—GPX4—breast cancer	0.000441	0.00357	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—IDH1—breast cancer	0.000431	0.00349	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SYNJ2—breast cancer	0.000418	0.00338	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NDUFS3—breast cancer	0.000388	0.00314	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—MED12—breast cancer	0.000374	0.00302	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CHST9—breast cancer	0.000365	0.00295	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	0.000357	0.00289	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	0.000347	0.00281	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—COX11—breast cancer	0.000346	0.0028	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	0.000341	0.00276	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ACHE—breast cancer	0.00033	0.00267	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SHMT1—breast cancer	0.000317	0.00256	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CDA—breast cancer	0.000317	0.00256	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	0.000313	0.00253	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	0.00031	0.0025	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SLCO1B1—breast cancer	0.000305	0.00247	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SLC2A5—breast cancer	0.000305	0.00247	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ALB—breast cancer	0.000301	0.00244	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	0.000298	0.00241	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APRT—breast cancer	0.000294	0.00238	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—FASN—breast cancer	0.000289	0.00234	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—BCHE—breast cancer	0.000288	0.00233	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ESRRA—breast cancer	0.000277	0.00224	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ANGPTL4—breast cancer	0.000277	0.00224	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—RAF1—breast cancer	0.000272	0.0022	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	0.000263	0.00213	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GPI—breast cancer	0.000262	0.00212	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HADHB—breast cancer	0.000262	0.00212	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—TGFB1—breast cancer	0.000255	0.00206	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	0.000251	0.00203	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ALDH7A1—breast cancer	0.00025	0.00203	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ALDH1A1—breast cancer	0.00025	0.00203	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	0.000247	0.002	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NME1—breast cancer	0.00024	0.00194	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ADSL—breast cancer	0.00024	0.00194	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PHGDH—breast cancer	0.00024	0.00194	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—UMPS—breast cancer	0.00024	0.00194	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—FHL2—breast cancer	0.00024	0.00194	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HPSE—breast cancer	0.000235	0.0019	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—BRIP1—breast cancer	0.000235	0.0019	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—LDHB—breast cancer	0.000235	0.0019	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HMMR—breast cancer	0.000223	0.00181	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ABCC1—breast cancer	0.000223	0.00181	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GSTA3—breast cancer	0.000223	0.00181	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PPARGC1B—breast cancer	0.000216	0.00175	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	0.00021	0.0017	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	0.00021	0.0017	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GSTA4—breast cancer	0.000204	0.00165	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CA9—breast cancer	0.000204	0.00165	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—GPX1—breast cancer	0.000201	0.00163	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	0.000199	0.00161	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GPX2—breast cancer	0.000199	0.00161	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GSTA2—breast cancer	0.000199	0.00161	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GPX4—breast cancer	0.000196	0.00159	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SULT1A1—breast cancer	0.000196	0.00159	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—IDH1—breast cancer	0.000192	0.00155	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GSTA1—breast cancer	0.000192	0.00155	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NAT2—breast cancer	0.00019	0.00153	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	0.000172	0.00139	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—DPYD—breast cancer	0.000166	0.00135	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—MED12—breast cancer	0.000166	0.00135	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ALDOA—breast cancer	0.000164	0.00132	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NCOA3—breast cancer	0.000159	0.00129	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SLC2A2—breast cancer	0.000158	0.00128	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	0.000156	0.00126	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ABCG2—breast cancer	0.000155	0.00125	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CPT1A—breast cancer	0.000155	0.00125	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—MTR—breast cancer	0.000155	0.00125	CbGpPWpGaD
Lubiprostone—Myalgia—Docetaxel—breast cancer	0.000153	0.000486	CcSEcCtD
Lubiprostone—Chest pain—Docetaxel—breast cancer	0.000153	0.000486	CcSEcCtD
Lubiprostone—Loss of consciousness—Capecitabine—breast cancer	0.000153	0.000486	CcSEcCtD
Lubiprostone—Nausea—Vinorelbine—breast cancer	0.000153	0.000486	CcSEcCtD
Lubiprostone—Dyspepsia—Paclitaxel—breast cancer	0.000152	0.000484	CcSEcCtD
Lubiprostone—Asthenia—Mitoxantrone—breast cancer	0.000152	0.000484	CcSEcCtD
Lubiprostone—Asthenia—Irinotecan—breast cancer	0.000152	0.000484	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000152	0.000483	CcSEcCtD
Lubiprostone—Cough—Capecitabine—breast cancer	0.000152	0.000483	CcSEcCtD
Lubiprostone—CBR1—Metabolism—HPGDS—breast cancer	0.000152	0.00123	CbGpPWpGaD
Lubiprostone—Urinary tract infection—Epirubicin—breast cancer	0.000151	0.000479	CcSEcCtD
Lubiprostone—CBR1—Metabolism—HBA1—breast cancer	0.000151	0.00122	CbGpPWpGaD
Lubiprostone—Decreased appetite—Paclitaxel—breast cancer	0.00015	0.000478	CcSEcCtD
Lubiprostone—Hypersensitivity—Fluorouracil—breast cancer	0.00015	0.000476	CcSEcCtD
Lubiprostone—Dry mouth—Docetaxel—breast cancer	0.00015	0.000476	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000149	0.000475	CcSEcCtD
Lubiprostone—Fatigue—Paclitaxel—breast cancer	0.000149	0.000474	CcSEcCtD
Lubiprostone—Pollakiuria—Doxorubicin—breast cancer	0.000149	0.000473	CcSEcCtD
Lubiprostone—Asthenia—Gemcitabine—breast cancer	0.000148	0.000472	CcSEcCtD
Lubiprostone—Chest pain—Capecitabine—breast cancer	0.000148	0.000471	CcSEcCtD
Lubiprostone—Myalgia—Capecitabine—breast cancer	0.000148	0.000471	CcSEcCtD
Lubiprostone—Pain—Paclitaxel—breast cancer	0.000148	0.000471	CcSEcCtD
Lubiprostone—Constipation—Paclitaxel—breast cancer	0.000148	0.000471	CcSEcCtD
Lubiprostone—Anxiety—Capecitabine—breast cancer	0.000148	0.000469	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GSTT1—breast cancer	0.000147	0.00119	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ACHE—breast cancer	0.000147	0.00119	CbGpPWpGaD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000147	0.000468	CcSEcCtD
Lubiprostone—Oedema—Docetaxel—breast cancer	0.000147	0.000466	CcSEcCtD
Lubiprostone—Weight increased—Doxorubicin—breast cancer	0.000146	0.000466	CcSEcCtD
Lubiprostone—Discomfort—Capecitabine—breast cancer	0.000146	0.000465	CcSEcCtD
Lubiprostone—Nausea—Thiotepa—breast cancer	0.000146	0.000464	CcSEcCtD
Lubiprostone—Diarrhoea—Mitoxantrone—breast cancer	0.000145	0.000462	CcSEcCtD
Lubiprostone—Diarrhoea—Irinotecan—breast cancer	0.000145	0.000462	CcSEcCtD
Lubiprostone—Dry mouth—Capecitabine—breast cancer	0.000145	0.000461	CcSEcCtD
Lubiprostone—Shock—Docetaxel—breast cancer	0.000144	0.000459	CcSEcCtD
Lubiprostone—Nervous system disorder—Docetaxel—breast cancer	0.000144	0.000457	CcSEcCtD
Lubiprostone—Tachycardia—Docetaxel—breast cancer	0.000143	0.000455	CcSEcCtD
Lubiprostone—Feeling abnormal—Paclitaxel—breast cancer	0.000143	0.000453	CcSEcCtD
Lubiprostone—Skin disorder—Docetaxel—breast cancer	0.000142	0.000453	CcSEcCtD
Lubiprostone—Oedema—Capecitabine—breast cancer	0.000142	0.000452	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Paclitaxel—breast cancer	0.000141	0.00045	CcSEcCtD
Lubiprostone—Diarrhoea—Gemcitabine—breast cancer	0.000141	0.00045	CcSEcCtD
Lubiprostone—Dizziness—Irinotecan—breast cancer	0.00014	0.000446	CcSEcCtD
Lubiprostone—Anorexia—Docetaxel—breast cancer	0.00014	0.000445	CcSEcCtD
Lubiprostone—Shock—Capecitabine—breast cancer	0.00014	0.000444	CcSEcCtD
Lubiprostone—Urinary tract infection—Doxorubicin—breast cancer	0.000139	0.000444	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CYP17A1—breast cancer	0.000139	0.00113	CbGpPWpGaD
Lubiprostone—Nervous system disorder—Capecitabine—breast cancer	0.000139	0.000443	CcSEcCtD
Lubiprostone—Diarrhoea—Fluorouracil—breast cancer	0.000139	0.000442	CcSEcCtD
Lubiprostone—Tachycardia—Capecitabine—breast cancer	0.000139	0.000441	CcSEcCtD
Lubiprostone—Skin disorder—Capecitabine—breast cancer	0.000138	0.000439	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ENO1—breast cancer	0.000138	0.00112	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PTGS1—breast cancer	0.000138	0.00112	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	0.000137	0.00111	CbGpPWpGaD
Lubiprostone—Hyperhidrosis—Capecitabine—breast cancer	0.000137	0.000437	CcSEcCtD
Lubiprostone—Oedema peripheral—Epirubicin—breast cancer	0.000137	0.000436	CcSEcCtD
Lubiprostone—Connective tissue disorder—Epirubicin—breast cancer	0.000137	0.000435	CcSEcCtD
Lubiprostone—Abdominal pain—Paclitaxel—breast cancer	0.000137	0.000435	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ALB—breast cancer	0.000136	0.0011	CbGpPWpGaD
Lubiprostone—Anorexia—Capecitabine—breast cancer	0.000135	0.00043	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CYP2D6—breast cancer	0.000135	0.00109	CbGpPWpGaD
Lubiprostone—Vomiting—Irinotecan—breast cancer	0.000135	0.000429	CcSEcCtD
Lubiprostone—Vomiting—Mitoxantrone—breast cancer	0.000135	0.000429	CcSEcCtD
Lubiprostone—Dizziness—Fluorouracil—breast cancer	0.000134	0.000427	CcSEcCtD
Lubiprostone—Mediastinal disorder—Methotrexate—breast cancer	0.000134	0.000426	CcSEcCtD
Lubiprostone—Rash—Mitoxantrone—breast cancer	0.000134	0.000425	CcSEcCtD
Lubiprostone—Rash—Irinotecan—breast cancer	0.000134	0.000425	CcSEcCtD
Lubiprostone—Dermatitis—Irinotecan—breast cancer	0.000134	0.000425	CcSEcCtD
Lubiprostone—Dermatitis—Mitoxantrone—breast cancer	0.000134	0.000425	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000134	0.000425	CcSEcCtD
Lubiprostone—Headache—Irinotecan—breast cancer	0.000133	0.000423	CcSEcCtD
Lubiprostone—Headache—Mitoxantrone—breast cancer	0.000133	0.000423	CcSEcCtD
Lubiprostone—CBR1—Metabolism—NCOA2—breast cancer	0.000133	0.00107	CbGpPWpGaD
Lubiprostone—Vomiting—Gemcitabine—breast cancer	0.000131	0.000418	CcSEcCtD
Lubiprostone—Dyspnoea—Docetaxel—breast cancer	0.000131	0.000416	CcSEcCtD
Lubiprostone—Mental disorder—Methotrexate—breast cancer	0.00013	0.000415	CcSEcCtD
Lubiprostone—Rash—Gemcitabine—breast cancer	0.00013	0.000414	CcSEcCtD
Lubiprostone—Dermatitis—Gemcitabine—breast cancer	0.00013	0.000414	CcSEcCtD
Lubiprostone—Malnutrition—Methotrexate—breast cancer	0.00013	0.000412	CcSEcCtD
Lubiprostone—Erythema—Methotrexate—breast cancer	0.00013	0.000412	CcSEcCtD
Lubiprostone—Headache—Gemcitabine—breast cancer	0.000129	0.000412	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000129	0.000411	CcSEcCtD
Lubiprostone—Vomiting—Fluorouracil—breast cancer	0.000129	0.000411	CcSEcCtD
Lubiprostone—Dyspepsia—Docetaxel—breast cancer	0.000129	0.000411	CcSEcCtD
Lubiprostone—CBR1—Metabolism—FASN—breast cancer	0.000129	0.00104	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—BCHE—breast cancer	0.000128	0.00104	CbGpPWpGaD
Lubiprostone—Rash—Fluorouracil—breast cancer	0.000128	0.000407	CcSEcCtD
Lubiprostone—Dermatitis—Fluorouracil—breast cancer	0.000128	0.000407	CcSEcCtD
Lubiprostone—Decreased appetite—Docetaxel—breast cancer	0.000127	0.000405	CcSEcCtD
Lubiprostone—Hypersensitivity—Paclitaxel—breast cancer	0.000127	0.000405	CcSEcCtD
Lubiprostone—Headache—Fluorouracil—breast cancer	0.000127	0.000405	CcSEcCtD
Lubiprostone—Oedema peripheral—Doxorubicin—breast cancer	0.000127	0.000404	CcSEcCtD
Lubiprostone—Dysgeusia—Methotrexate—breast cancer	0.000127	0.000403	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Docetaxel—breast cancer	0.000127	0.000403	CcSEcCtD
Lubiprostone—Connective tissue disorder—Doxorubicin—breast cancer	0.000127	0.000403	CcSEcCtD
Lubiprostone—CBR1—Metabolism—SLC5A5—breast cancer	0.000127	0.00102	CbGpPWpGaD
Lubiprostone—Dyspnoea—Capecitabine—breast cancer	0.000127	0.000403	CcSEcCtD
Lubiprostone—Fatigue—Docetaxel—breast cancer	0.000126	0.000402	CcSEcCtD
Lubiprostone—Nausea—Irinotecan—breast cancer	0.000126	0.000401	CcSEcCtD
Lubiprostone—Nausea—Mitoxantrone—breast cancer	0.000126	0.000401	CcSEcCtD
Lubiprostone—Mediastinal disorder—Epirubicin—breast cancer	0.000125	0.000399	CcSEcCtD
Lubiprostone—Pain—Docetaxel—breast cancer	0.000125	0.000399	CcSEcCtD
Lubiprostone—Constipation—Docetaxel—breast cancer	0.000125	0.000399	CcSEcCtD
Lubiprostone—Dyspepsia—Capecitabine—breast cancer	0.000125	0.000397	CcSEcCtD
Lubiprostone—Asthenia—Paclitaxel—breast cancer	0.000124	0.000395	CcSEcCtD
Lubiprostone—Decreased appetite—Capecitabine—breast cancer	0.000123	0.000393	CcSEcCtD
Lubiprostone—Nausea—Gemcitabine—breast cancer	0.000123	0.00039	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Capecitabine—breast cancer	0.000123	0.00039	CcSEcCtD
Lubiprostone—Fatigue—Capecitabine—breast cancer	0.000122	0.000389	CcSEcCtD
Lubiprostone—CBR1—Metabolism—NQO1—breast cancer	0.000122	0.000989	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SLC2A1—breast cancer	0.000122	0.000989	CbGpPWpGaD
Lubiprostone—Mental disorder—Epirubicin—breast cancer	0.000122	0.000388	CcSEcCtD
Lubiprostone—Pain—Capecitabine—breast cancer	0.000121	0.000386	CcSEcCtD
Lubiprostone—Constipation—Capecitabine—breast cancer	0.000121	0.000386	CcSEcCtD
Lubiprostone—Erythema—Epirubicin—breast cancer	0.000121	0.000385	CcSEcCtD
Lubiprostone—Malnutrition—Epirubicin—breast cancer	0.000121	0.000385	CcSEcCtD
Lubiprostone—Feeling abnormal—Docetaxel—breast cancer	0.000121	0.000384	CcSEcCtD
Lubiprostone—Nausea—Fluorouracil—breast cancer	0.000121	0.000384	CcSEcCtD
Lubiprostone—Ill-defined disorder—Methotrexate—breast cancer	0.00012	0.000382	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Docetaxel—breast cancer	0.00012	0.000381	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	0.00012	0.000968	CbGpPWpGaD
Lubiprostone—Flatulence—Epirubicin—breast cancer	0.000119	0.00038	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CYP3A4—breast cancer	0.000119	0.000964	CbGpPWpGaD
Lubiprostone—Dysgeusia—Epirubicin—breast cancer	0.000119	0.000377	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	0.000119	0.00096	CbGpPWpGaD
Lubiprostone—Diarrhoea—Paclitaxel—breast cancer	0.000118	0.000376	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CYP1B1—breast cancer	0.000117	0.000948	CbGpPWpGaD
Lubiprostone—Feeling abnormal—Capecitabine—breast cancer	0.000117	0.000372	CcSEcCtD
Lubiprostone—Malaise—Methotrexate—breast cancer	0.000117	0.000371	CcSEcCtD
Lubiprostone—Muscle spasms—Epirubicin—breast cancer	0.000117	0.000371	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Capecitabine—breast cancer	0.000116	0.000369	CcSEcCtD
Lubiprostone—Mediastinal disorder—Doxorubicin—breast cancer	0.000116	0.000369	CcSEcCtD
Lubiprostone—Abdominal pain—Docetaxel—breast cancer	0.000116	0.000369	CcSEcCtD
Lubiprostone—CBR1—Metabolism—HSP90AA1—breast cancer	0.000115	0.00093	CbGpPWpGaD
Lubiprostone—Dizziness—Paclitaxel—breast cancer	0.000114	0.000364	CcSEcCtD
Lubiprostone—Cough—Methotrexate—breast cancer	0.000113	0.000359	CcSEcCtD
Lubiprostone—Mental disorder—Doxorubicin—breast cancer	0.000113	0.000359	CcSEcCtD
Lubiprostone—Ill-defined disorder—Epirubicin—breast cancer	0.000112	0.000358	CcSEcCtD
Lubiprostone—Abdominal pain—Capecitabine—breast cancer	0.000112	0.000357	CcSEcCtD
Lubiprostone—Erythema—Doxorubicin—breast cancer	0.000112	0.000357	CcSEcCtD
Lubiprostone—Malnutrition—Doxorubicin—breast cancer	0.000112	0.000357	CcSEcCtD
Lubiprostone—CBR1—Metabolism—NCOA1—breast cancer	0.000112	0.000905	CbGpPWpGaD
Lubiprostone—Flatulence—Doxorubicin—breast cancer	0.00011	0.000351	CcSEcCtD
Lubiprostone—Chest pain—Methotrexate—breast cancer	0.00011	0.000351	CcSEcCtD
Lubiprostone—Myalgia—Methotrexate—breast cancer	0.00011	0.000351	CcSEcCtD
Lubiprostone—CBR1—Metabolism—STK11—breast cancer	0.00011	0.000891	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CYP19A1—breast cancer	0.00011	0.000891	CbGpPWpGaD
Lubiprostone—Vomiting—Paclitaxel—breast cancer	0.00011	0.00035	CcSEcCtD
Lubiprostone—Dysgeusia—Doxorubicin—breast cancer	0.00011	0.000349	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000109	0.000348	CcSEcCtD
Lubiprostone—Malaise—Epirubicin—breast cancer	0.000109	0.000348	CcSEcCtD
Lubiprostone—Rash—Paclitaxel—breast cancer	0.000109	0.000347	CcSEcCtD
Lubiprostone—Dermatitis—Paclitaxel—breast cancer	0.000109	0.000347	CcSEcCtD
Lubiprostone—Discomfort—Methotrexate—breast cancer	0.000109	0.000346	CcSEcCtD
Lubiprostone—Syncope—Epirubicin—breast cancer	0.000109	0.000346	CcSEcCtD
Lubiprostone—Headache—Paclitaxel—breast cancer	0.000108	0.000345	CcSEcCtD
Lubiprostone—Hypersensitivity—Docetaxel—breast cancer	0.000108	0.000344	CcSEcCtD
Lubiprostone—Muscle spasms—Doxorubicin—breast cancer	0.000108	0.000343	CcSEcCtD
Lubiprostone—Palpitations—Epirubicin—breast cancer	0.000107	0.000341	CcSEcCtD
Lubiprostone—Loss of consciousness—Epirubicin—breast cancer	0.000107	0.000339	CcSEcCtD
Lubiprostone—Cough—Epirubicin—breast cancer	0.000106	0.000336	CcSEcCtD
Lubiprostone—Asthenia—Docetaxel—breast cancer	0.000105	0.000335	CcSEcCtD
Lubiprostone—Hypersensitivity—Capecitabine—breast cancer	0.000105	0.000333	CcSEcCtD
Lubiprostone—Ill-defined disorder—Doxorubicin—breast cancer	0.000104	0.000331	CcSEcCtD
Lubiprostone—Nervous system disorder—Methotrexate—breast cancer	0.000104	0.00033	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	0.000103	0.000837	CbGpPWpGaD
Lubiprostone—Myalgia—Epirubicin—breast cancer	0.000103	0.000328	CcSEcCtD
Lubiprostone—Chest pain—Epirubicin—breast cancer	0.000103	0.000328	CcSEcCtD
Lubiprostone—Anxiety—Epirubicin—breast cancer	0.000103	0.000327	CcSEcCtD
Lubiprostone—Nausea—Paclitaxel—breast cancer	0.000103	0.000327	CcSEcCtD
Lubiprostone—Skin disorder—Methotrexate—breast cancer	0.000103	0.000326	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000102	0.000326	CcSEcCtD
Lubiprostone—CBR1—Metabolism—COMT—breast cancer	0.000102	0.000829	CbGpPWpGaD
Lubiprostone—Hyperhidrosis—Methotrexate—breast cancer	0.000102	0.000325	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GSTP1—breast cancer	0.000102	0.000825	CbGpPWpGaD
Lubiprostone—Discomfort—Epirubicin—breast cancer	0.000102	0.000324	CcSEcCtD
Lubiprostone—Asthenia—Capecitabine—breast cancer	0.000102	0.000324	CcSEcCtD
Lubiprostone—Malaise—Doxorubicin—breast cancer	0.000101	0.000322	CcSEcCtD
Lubiprostone—Dry mouth—Epirubicin—breast cancer	0.000101	0.000321	CcSEcCtD
Lubiprostone—Anorexia—Methotrexate—breast cancer	0.000101	0.00032	CcSEcCtD
Lubiprostone—Syncope—Doxorubicin—breast cancer	0.000101	0.00032	CcSEcCtD
Lubiprostone—CBR1—Metabolism—HMOX1—breast cancer	0.000101	0.000814	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ITPR1—breast cancer	0.0001	0.000812	CbGpPWpGaD
Lubiprostone—Diarrhoea—Docetaxel—breast cancer	0.0001	0.000319	CcSEcCtD
Lubiprostone—Palpitations—Doxorubicin—breast cancer	9.91e-05	0.000315	CcSEcCtD
Lubiprostone—Oedema—Epirubicin—breast cancer	9.89e-05	0.000315	CcSEcCtD
Lubiprostone—Loss of consciousness—Doxorubicin—breast cancer	9.86e-05	0.000313	CcSEcCtD
Lubiprostone—Cough—Doxorubicin—breast cancer	9.79e-05	0.000311	CcSEcCtD
Lubiprostone—Shock—Epirubicin—breast cancer	9.73e-05	0.000309	CcSEcCtD
Lubiprostone—Diarrhoea—Capecitabine—breast cancer	9.71e-05	0.000309	CcSEcCtD
Lubiprostone—Nervous system disorder—Epirubicin—breast cancer	9.7e-05	0.000308	CcSEcCtD
Lubiprostone—Dizziness—Docetaxel—breast cancer	9.7e-05	0.000308	CcSEcCtD
Lubiprostone—Tachycardia—Epirubicin—breast cancer	9.65e-05	0.000307	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ABCB1—breast cancer	9.65e-05	0.000781	CbGpPWpGaD
Lubiprostone—Musculoskeletal discomfort—Methotrexate—breast cancer	9.63e-05	0.000306	CcSEcCtD
Lubiprostone—Skin disorder—Epirubicin—breast cancer	9.61e-05	0.000306	CcSEcCtD
Lubiprostone—Hyperhidrosis—Epirubicin—breast cancer	9.56e-05	0.000304	CcSEcCtD
Lubiprostone—Chest pain—Doxorubicin—breast cancer	9.55e-05	0.000304	CcSEcCtD
Lubiprostone—Myalgia—Doxorubicin—breast cancer	9.55e-05	0.000304	CcSEcCtD
Lubiprostone—Anxiety—Doxorubicin—breast cancer	9.51e-05	0.000303	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	9.48e-05	0.000302	CcSEcCtD
Lubiprostone—CBR1—Metabolism—TYMS—breast cancer	9.48e-05	0.000767	CbGpPWpGaD
Lubiprostone—Discomfort—Doxorubicin—breast cancer	9.43e-05	0.0003	CcSEcCtD
Lubiprostone—Anorexia—Epirubicin—breast cancer	9.43e-05	0.0003	CcSEcCtD
Lubiprostone—Dyspnoea—Methotrexate—breast cancer	9.42e-05	0.0003	CcSEcCtD
Lubiprostone—Dizziness—Capecitabine—breast cancer	9.39e-05	0.000299	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GSTM1—breast cancer	9.37e-05	0.000758	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PLA2G4A—breast cancer	9.37e-05	0.000758	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NCOR1—breast cancer	9.37e-05	0.000758	CbGpPWpGaD
Lubiprostone—Dry mouth—Doxorubicin—breast cancer	9.34e-05	0.000297	CcSEcCtD
Lubiprostone—Vomiting—Docetaxel—breast cancer	9.32e-05	0.000297	CcSEcCtD
Lubiprostone—Dyspepsia—Methotrexate—breast cancer	9.3e-05	0.000296	CcSEcCtD
Lubiprostone—Rash—Docetaxel—breast cancer	9.25e-05	0.000294	CcSEcCtD
Lubiprostone—Dermatitis—Docetaxel—breast cancer	9.24e-05	0.000294	CcSEcCtD
Lubiprostone—Decreased appetite—Methotrexate—breast cancer	9.19e-05	0.000292	CcSEcCtD
Lubiprostone—Headache—Docetaxel—breast cancer	9.19e-05	0.000292	CcSEcCtD
Lubiprostone—Oedema—Doxorubicin—breast cancer	9.15e-05	0.000291	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Methotrexate—breast cancer	9.12e-05	0.00029	CcSEcCtD
Lubiprostone—Fatigue—Methotrexate—breast cancer	9.11e-05	0.00029	CcSEcCtD
Lubiprostone—Pain—Methotrexate—breast cancer	9.04e-05	0.000287	CcSEcCtD
Lubiprostone—Vomiting—Capecitabine—breast cancer	9.03e-05	0.000287	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Epirubicin—breast cancer	9.01e-05	0.000287	CcSEcCtD
Lubiprostone—Shock—Doxorubicin—breast cancer	9e-05	0.000286	CcSEcCtD
Lubiprostone—Nervous system disorder—Doxorubicin—breast cancer	8.97e-05	0.000285	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GPX1—breast cancer	8.97e-05	0.000726	CbGpPWpGaD
Lubiprostone—Rash—Capecitabine—breast cancer	8.95e-05	0.000285	CcSEcCtD
Lubiprostone—Dermatitis—Capecitabine—breast cancer	8.94e-05	0.000284	CcSEcCtD
Lubiprostone—Tachycardia—Doxorubicin—breast cancer	8.93e-05	0.000284	CcSEcCtD
Lubiprostone—Headache—Capecitabine—breast cancer	8.89e-05	0.000283	CcSEcCtD
Lubiprostone—Skin disorder—Doxorubicin—breast cancer	8.89e-05	0.000283	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CYP1A1—breast cancer	8.88e-05	0.000719	CbGpPWpGaD
Lubiprostone—Hyperhidrosis—Doxorubicin—breast cancer	8.85e-05	0.000281	CcSEcCtD
Lubiprostone—Dyspnoea—Epirubicin—breast cancer	8.82e-05	0.00028	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ERCC2—breast cancer	8.81e-05	0.000713	CbGpPWpGaD
Lubiprostone—Anorexia—Doxorubicin—breast cancer	8.72e-05	0.000277	CcSEcCtD
Lubiprostone—Nausea—Docetaxel—breast cancer	8.71e-05	0.000277	CcSEcCtD
Lubiprostone—Feeling abnormal—Methotrexate—breast cancer	8.71e-05	0.000277	CcSEcCtD
Lubiprostone—Dyspepsia—Epirubicin—breast cancer	8.71e-05	0.000277	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Methotrexate—breast cancer	8.64e-05	0.000275	CcSEcCtD
Lubiprostone—Decreased appetite—Epirubicin—breast cancer	8.6e-05	0.000273	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Epirubicin—breast cancer	8.54e-05	0.000272	CcSEcCtD
Lubiprostone—Fatigue—Epirubicin—breast cancer	8.53e-05	0.000271	CcSEcCtD
Lubiprostone—Pain—Epirubicin—breast cancer	8.46e-05	0.000269	CcSEcCtD
Lubiprostone—Constipation—Epirubicin—breast cancer	8.46e-05	0.000269	CcSEcCtD
Lubiprostone—Nausea—Capecitabine—breast cancer	8.43e-05	0.000268	CcSEcCtD
Lubiprostone—Abdominal pain—Methotrexate—breast cancer	8.35e-05	0.000266	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Doxorubicin—breast cancer	8.34e-05	0.000265	CcSEcCtD
Lubiprostone—CBR1—Metabolism—MTHFR—breast cancer	8.28e-05	0.00067	CbGpPWpGaD
Lubiprostone—Dyspnoea—Doxorubicin—breast cancer	8.16e-05	0.000259	CcSEcCtD
Lubiprostone—Feeling abnormal—Epirubicin—breast cancer	8.15e-05	0.000259	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Epirubicin—breast cancer	8.09e-05	0.000257	CcSEcCtD
Lubiprostone—Dyspepsia—Doxorubicin—breast cancer	8.06e-05	0.000256	CcSEcCtD
Lubiprostone—Decreased appetite—Doxorubicin—breast cancer	7.96e-05	0.000253	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Doxorubicin—breast cancer	7.9e-05	0.000251	CcSEcCtD
Lubiprostone—Fatigue—Doxorubicin—breast cancer	7.89e-05	0.000251	CcSEcCtD
Lubiprostone—Pain—Doxorubicin—breast cancer	7.83e-05	0.000249	CcSEcCtD
Lubiprostone—Constipation—Doxorubicin—breast cancer	7.83e-05	0.000249	CcSEcCtD
Lubiprostone—Abdominal pain—Epirubicin—breast cancer	7.82e-05	0.000249	CcSEcCtD
Lubiprostone—Hypersensitivity—Methotrexate—breast cancer	7.79e-05	0.000248	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CAV1—breast cancer	7.64e-05	0.000618	CbGpPWpGaD
Lubiprostone—Asthenia—Methotrexate—breast cancer	7.58e-05	0.000241	CcSEcCtD
Lubiprostone—Feeling abnormal—Doxorubicin—breast cancer	7.54e-05	0.00024	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Doxorubicin—breast cancer	7.48e-05	0.000238	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.3e-05	0.00059	CbGpPWpGaD
Lubiprostone—Hypersensitivity—Epirubicin—breast cancer	7.29e-05	0.000232	CcSEcCtD
Lubiprostone—Abdominal pain—Doxorubicin—breast cancer	7.23e-05	0.00023	CcSEcCtD
Lubiprostone—Diarrhoea—Methotrexate—breast cancer	7.23e-05	0.00023	CcSEcCtD
Lubiprostone—Asthenia—Epirubicin—breast cancer	7.1e-05	0.000226	CcSEcCtD
Lubiprostone—Dizziness—Methotrexate—breast cancer	6.99e-05	0.000222	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PIK3CG—breast cancer	6.96e-05	0.000563	CbGpPWpGaD
Lubiprostone—Diarrhoea—Epirubicin—breast cancer	6.77e-05	0.000215	CcSEcCtD
Lubiprostone—Hypersensitivity—Doxorubicin—breast cancer	6.74e-05	0.000214	CcSEcCtD
Lubiprostone—Vomiting—Methotrexate—breast cancer	6.72e-05	0.000214	CcSEcCtD
Lubiprostone—Rash—Methotrexate—breast cancer	6.66e-05	0.000212	CcSEcCtD
Lubiprostone—Dermatitis—Methotrexate—breast cancer	6.66e-05	0.000212	CcSEcCtD
Lubiprostone—Headache—Methotrexate—breast cancer	6.62e-05	0.000211	CcSEcCtD
Lubiprostone—Asthenia—Doxorubicin—breast cancer	6.57e-05	0.000209	CcSEcCtD
Lubiprostone—Dizziness—Epirubicin—breast cancer	6.54e-05	0.000208	CcSEcCtD
Lubiprostone—Vomiting—Epirubicin—breast cancer	6.29e-05	0.0002	CcSEcCtD
Lubiprostone—Nausea—Methotrexate—breast cancer	6.28e-05	0.0002	CcSEcCtD
Lubiprostone—Diarrhoea—Doxorubicin—breast cancer	6.26e-05	0.000199	CcSEcCtD
Lubiprostone—Rash—Epirubicin—breast cancer	6.24e-05	0.000198	CcSEcCtD
Lubiprostone—Dermatitis—Epirubicin—breast cancer	6.23e-05	0.000198	CcSEcCtD
Lubiprostone—Headache—Epirubicin—breast cancer	6.2e-05	0.000197	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PIK3CD—breast cancer	6.12e-05	0.000495	CbGpPWpGaD
Lubiprostone—Dizziness—Doxorubicin—breast cancer	6.05e-05	0.000192	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ALB—breast cancer	6.04e-05	0.000488	CbGpPWpGaD
Lubiprostone—Nausea—Epirubicin—breast cancer	5.88e-05	0.000187	CcSEcCtD
Lubiprostone—Vomiting—Doxorubicin—breast cancer	5.82e-05	0.000185	CcSEcCtD
Lubiprostone—CBR1—Metabolism—NOS3—breast cancer	5.78e-05	0.000467	CbGpPWpGaD
Lubiprostone—Rash—Doxorubicin—breast cancer	5.77e-05	0.000184	CcSEcCtD
Lubiprostone—Dermatitis—Doxorubicin—breast cancer	5.76e-05	0.000183	CcSEcCtD
Lubiprostone—Headache—Doxorubicin—breast cancer	5.73e-05	0.000182	CcSEcCtD
Lubiprostone—Nausea—Doxorubicin—breast cancer	5.44e-05	0.000173	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PIK3CB—breast cancer	5.33e-05	0.000431	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PTGS2—breast cancer	5.28e-05	0.000427	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PTEN—breast cancer	4.61e-05	0.000373	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PIK3CA—breast cancer	3.25e-05	0.000263	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—AKT1—breast cancer	2.65e-05	0.000215	CbGpPWpGaD
